Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;27(4):990-996.
doi: 10.1007/s11695-016-2410-y.

One-Anastomosis Jejunal Interposition With Gastric Remnant Resection (Branco-Zorron Switch) for Severe Recurrent Hyperinsulinemic Hypoglycemia After Gastric Bypass for Morbid Obesity

Affiliations

One-Anastomosis Jejunal Interposition With Gastric Remnant Resection (Branco-Zorron Switch) for Severe Recurrent Hyperinsulinemic Hypoglycemia After Gastric Bypass for Morbid Obesity

Ricardo Zorron et al. Obes Surg. .

Abstract

Background: The anatomical and physiological changes after Roux-en-Y gastric bypass for morbid obesity can lead to severe hyperinsulinemic hypoglycemia with neuroglycopenia in a small percentage of patients. The exact physiologic mechanism is not completely understood. Surgical reversal to the original anatomy and distal or total pancreatectomy are current therapeutic options to reverse the hypoglycemic effect, with substantial associated morbidity. Our group reports a pilot clinical series of a novel surgical technique using one-anastomosis jejunal interposition with gastric remnant resection (Branco-Zorron Switch).

Methods: Patients with severe symptomatic hyperinsulinemic hypoglycemia refractory to conservative therapy were treated using the technique. The procedure started with resection of the remnant stomach close to pylorus. The alimentary limb was sectioned at 20 cm from the gastrojejunal anastomosis, and the rest of the alimentary limb was resected until the Y-Roux anastomosis. A hand-sutured anastomosis was then performed with the proximal alimentary limb and the remnant antrum.

Results: Four patients were successfully submitted to the procedure with reversal of the symptomatology and normalization of insulin levels, postprandial glucose levels, and oral glucose tolerance test, with a mean follow-up of 24.3 months. Mean operative time was 188 min, and patients recovered without postoperative complications.

Conclusion: Patients suffering from severe hyperinsulinemic hypoglycemia after gastric bypass may be efficiently treated by this innovative procedure, avoiding extreme surgical therapy such as pancreatectomy or restoring the gastric anatomy, while still maintaining sustained weight loss. Studies with larger series and longer follow-up are still needed to define the role of this therapy in managing this entity.

Keywords: Bariatric surgery; Gastric bypass; Hyperinsulinemia; Hypoglycemia; Morbid obesity; NIPHS; Non-insulinoma pancreatogenous hyperinsulinemic hypoglycemia syndrome.

Similar articles

See all similar articles

References

    1. Obes Surg. 2007 May;17(5):592-4 - PubMed
    1. N Engl J Med. 2005 Jul 21;353(3):249-54 - PubMed
    1. Surg Obes Relat Dis. 2014 Jan-Feb;10(1):36-43 - PubMed
    1. Obes Surg. 2016 Aug;26(8):1978-84 - PubMed
    1. Diabetes Care. 2006 Jul;29(7):1554-9 - PubMed

LinkOut - more resources

Feedback